Equities

Biofil Chemicals and Pharmaceuticals Ltd

BIOFILCHEM:NSI

Biofil Chemicals and Pharmaceuticals Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (INR)83.60
  • Today's Change6.30 / 8.15%
  • Shares traded547.46k
  • 1 Year change+68.55%
  • Beta2.4007
Data delayed at least 15 minutes, as of Sep 20 2024 11:15 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of INR
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
ASSETS
Cash And Short Term Investments230.381.45
Total Receivables, Net33020572
Total Inventory251213
Prepaid expenses------
Other current assets, total5.456.007.01
Total current assets38422493
Property, plant & equipment, net869094
Goodwill, net------
Intangibles, net------
Long term investments------
Note receivable - long term------
Other long term assets0.510.510.00
Total assets471314187
LIABILITIES
Accounts payable2761265.96
Accrued expenses------
Notes payable/short-term debt4.395.224.65
Current portion long-term debt/capital leases------
Other current liabilities, total5.315.534.34
Total current liabilities28513715
Total long term debt000
Total debt4.395.224.65
Deferred income tax3.553.794.00
Minority interest------
Other liabilities, total------
Total liabilities28914119
SHAREHOLDERS EQUITY
Common stock163163163
Additional paid-in capital171717
Retained earnings (accumulated deficit)2.01(7.01)(12)
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total------
Total equity182173168
Total liabilities & shareholders' equity471314187
Total common shares outstanding161616
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.